Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)
China
· Delayed Price · Currency is CNY 106.62
-0.39 (-0.36%)
Mar 9, 2026, 3:04 PM CST
SHE:300436 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -197.25 | -156.3 | -348.59 | -127.4 | -34.89 | 14.82 | Upgrade
|
| Depreciation & Amortization | 95.1 | 95.1 | 72.14 | 58.6 | 51.98 | 37.31 | Upgrade
|
| Other Amortization | 6.2 | 6.2 | 5.35 | 3.16 | 1.09 | 0.74 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | -0.01 | 0.02 | - | 0.31 | 2.16 | Upgrade
|
| Asset Writedown & Restructuring Costs | 75.15 | 75.15 | 8.47 | 4.72 | 3.93 | 0.32 | Upgrade
|
| Loss (Gain) From Sale of Investments | 11 | 11 | 61.84 | -70.52 | -26.68 | -12.46 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | 0.58 | - | - | Upgrade
|
| Other Operating Activities | 32.65 | 19.38 | 8.65 | -2.56 | 9.85 | 10.65 | Upgrade
|
| Change in Accounts Receivable | -97.71 | -97.71 | -75.45 | -10.98 | -8.18 | 1.88 | Upgrade
|
| Change in Inventory | -37.66 | -37.66 | -49.3 | 9.29 | -30.83 | -20.37 | Upgrade
|
| Change in Accounts Payable | 78.57 | 78.57 | 74.72 | 51.5 | 36.62 | -10.15 | Upgrade
|
| Change in Other Net Operating Assets | 27.03 | 27.03 | -2.34 | -6.66 | -1.42 | -2.22 | Upgrade
|
| Operating Cash Flow | -6.97 | 20.71 | -174.6 | -119.68 | -17.76 | 15.6 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | -54.11% | Upgrade
|
| Capital Expenditures | -48.32 | -66.99 | -201.24 | -195.96 | -174.41 | -54.45 | Upgrade
|
| Sale of Property, Plant & Equipment | 4.51 | 4.5 | 0.03 | 0.02 | 0.02 | 37.05 | Upgrade
|
| Investment in Securities | - | -1.06 | -9.54 | -1.57 | - | -17.6 | Upgrade
|
| Other Investing Activities | 0.09 | 17.73 | 3.34 | 0.3 | - | - | Upgrade
|
| Investing Cash Flow | -43.72 | -45.81 | -207.41 | -197.21 | -174.38 | -35.01 | Upgrade
|
| Long-Term Debt Issued | - | 350.8 | 402.06 | 372.2 | 152.33 | 210.02 | Upgrade
|
| Long-Term Debt Repaid | - | -367.84 | -254.99 | -248.68 | -193.01 | -129 | Upgrade
|
| Total Debt Repaid | -312.59 | -367.84 | -254.99 | -248.68 | -193.01 | -129 | Upgrade
|
| Net Debt Issued (Repaid) | -9.09 | -17.04 | 147.07 | 123.52 | -40.68 | 81.02 | Upgrade
|
| Issuance of Common Stock | - | - | - | 15.3 | 503.89 | - | Upgrade
|
| Common Dividends Paid | -15.77 | -17.42 | -17.4 | -10.35 | -9.17 | -8.84 | Upgrade
|
| Other Financing Activities | 190.55 | - | 220.05 | 34.07 | -8.46 | -10.5 | Upgrade
|
| Financing Cash Flow | 165.69 | -34.46 | 349.71 | 162.53 | 445.58 | 61.68 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | 0 | 0 | -0.01 | - | - | Upgrade
|
| Net Cash Flow | 115.01 | -59.56 | -32.29 | -154.36 | 253.43 | 42.27 | Upgrade
|
| Free Cash Flow | -55.28 | -46.28 | -375.83 | -315.64 | -192.17 | -38.86 | Upgrade
|
| Free Cash Flow Margin | -12.83% | -10.48% | -88.91% | -81.82% | -51.88% | -10.54% | Upgrade
|
| Free Cash Flow Per Share | -0.35 | -0.29 | -2.36 | -1.98 | -1.29 | -0.28 | Upgrade
|
| Cash Income Tax Paid | 61.43 | 59.61 | 54.22 | 48.37 | 31.83 | 38.91 | Upgrade
|
| Levered Free Cash Flow | -81.57 | -114.47 | -244.16 | -261.28 | -215.43 | 4.35 | Upgrade
|
| Unlevered Free Cash Flow | -60.37 | -92.25 | -222.27 | -254.66 | -209.72 | 9.93 | Upgrade
|
| Change in Working Capital | -29.8 | -29.8 | 17.52 | 13.75 | -23.36 | -37.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.